Streetbeat News

Regulatory

AMAT

ASML

BTCUSD

NVDA

SMH

The article discusses the geopolitical tensions between the US, Iran, and Israel, and their impact on oil prices. It also highlights the Biden administration's move to tighten export controls to prevent China from acquiring advanced technologies, especially in semiconductors. This has implications for semiconductor companies with significant sales in China. The article also mentions positive and negative money flows in various tech companies and ETFs. Finally, it discusses the SEC's decision not to appeal in the Grayscale case, which could potentially lead to Grayscale Bitcoin Trust becoming an ETF.

Portfolio Pulse from The Arora Report

October 16, 2023 | 3:03 pm

BLK

DOGEUSD

Dogecoin (CRYPTO: DOGE) traded higher by as much as 3% to the $0.061 level Monday morning before falling amid false rumors of the iShares Bitcoin Spot ETF receiving approval. BlackRock, which owns iShares, denied the rumors. The false information led to a surge in demand for Dogecoin, pushing its price higher. However, Dogecoin is trading nearly flat at the $0.059-level Monday morning.

Portfolio Pulse from Henry Khederian

October 16, 2023 | 3:00 pm

BLK

BTCUSD

Cointelegraph has apologized for disseminating inaccurate information regarding the approval of Blackrock's Bitcoin ETF. An internal investigation is underway and the findings will be shared with the public.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:51 pm

AAPL

ALB

AZN

BTCUSD

CVS

HON

MANU

NVAX

NWSA

PFE

RAD

WBA

Bitcoin's price spiked on false rumors of an ETF approval by BlackRock. Albemarle Corporation withdrew its offer to acquire Liontown Resources. Pfizer cut its annual revenue guidance by $9B due to a slump in COVID-19 vaccine sales, and BioNTech warned of €900M write-offs. Rite Aid filed for Chapter 11 bankruptcy. AstraZeneca's Tagrisso-Chemo combo is under FDA priority review. Honeywell projects a 10% increase in new business jet deliveries in 2024. WeWork appointed David Tolley as CEO. Novavax faces a setback as the EMA delays a decision on its COVID-19 vaccine. Activist shareholder Starboard Value acquired a stake in News Corp. Goldman Sachs is reconsidering its consumer lending venture. Manchester United shares fell as the Qatari group pulled away from acquisition. Apple is reshuffling its executive ranks and focusing on reducing the price of Vision Pro. Walgreens and CVS pharmacy staff are planning a nationwide walkout over poor working conditions.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 2:35 pm

AHG

Akso Health Group (NASDAQ:AHG) has regained compliance with Nasdaq's minimum bid price requirement. The company had previously received a notification for failing to maintain a minimum bid price of $1.00 over 30 consecutive business days. However, the closing bid price of the company's ADS was at $1.00 per share or greater from September 15, 2023 to October 10, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:32 pm

SPY

Federal Reserve's Harker has stated that the current interest rate environment is draining the housing market of new buyers. He also reiterated that the U.S. Central Bank is very likely done with rate hikes.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:32 pm

SPY

VGK

U.S. Treasury Secretary Janet Yellen has expressed confidence that Congress will approve aid for Ukraine, despite current opposition. Both the U.S. and EU are committed to supporting Ukraine.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:31 pm

SPY

VGK

U.S. Treasury Secretary Yellen stated that decoupling from China is not an option for the U.S. or EU. The White House is also preparing a supplemental request for aid to Ukraine and Israel.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:30 pm

AZN

AstraZeneca's supplemental New Drug Application for Tagrisso in combination with chemotherapy has been granted Priority Review by the FDA for locally advanced or metastatic non-small cell lung cancer (NSCLC). The FDA decision is expected in Q1 2024. The application is based on data from the FLAURA2 Phase 3 trial, which showed that the combination reduced the risk of disease progression or death by 38% compared to Tagrisso alone. AstraZeneca's shares are up 0.04% at $67.36.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 2:20 pm

GEHC

GE HealthCare (NASDAQ:GEHC) has received FDA clearance for its Allia IGS Pulse, a next-generation image-guided system designed for cardiac imaging. The system is designed to improve workflow for diagnosing and treating cardiovascular diseases. It features the first monopolar x-ray tube used for interventional procedures, providing exceptional image quality and optimized dose management for all patient sizes. The Allia IGS Pulse has been in pilot operations at Clinique Pasteur in Toulouse, France since January 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:17 pm